| Record ID | ia:serotoninscienti0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/serotoninscienti0000unse/serotoninscienti0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/serotoninscienti0000unse/serotoninscienti0000unse_meta.mrc |
LEADER: 02883cam 2200769 a 4500
001 ocm34597554
003 OCoLC
005 20200417012237.0
008 960329s1995 enka b 101 0 eng
010 $a 97140252
040 $aUk$beng$cDLC$dUKM$dNLM$dOCL$dBTCTA$dOCLCG$dGEBAY$dOCLCO$dOCLCF$dOCLCQ$dOCL$dEUW$dOCLCQ$dUKMGB$dOCLCO$dOCLCA
015 $aGB9630059$2bnb
016 7 $a9711596$2DNLM
016 7 $a009096424$2Uk
016 7 $a006338387$2Uk
020 $a1854031058
020 $a9781854031051
035 $a(OCoLC)34597554
042 $alccopycat
050 04 $aRC271.C5$bS49 1995
060 00 $a1997 G-660
060 10 $aQV 126$bS48485 1995
082 00 $a616.99/4061$221
245 00 $aSerotonin and the scientific basis of anti-emetic therapy /$cedited by D.J.M. Reynolds, P.L.R. Andrews, and C.J. Davis.
260 $aOxford ;$aPhiladelphia :$bOxford Clinical Communications,$c℗♭1995.
300 $a286 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $aConference proceedings.
504 $aIncludes bibliographical references and index.
650 0 $aAntiemetics$vCongresses.
650 0 $aCancer$xChemotherapy$xComplications$xTreatment$vCongresses.
650 0 $aSerotonin uptake inhibitors$vCongresses.
650 0 $aSerotonin$xAntagonists$vCongresses.
650 0 $aAntineoplastic agents$xSide effects$vCongresses.
650 7 $aAntiemetics.$2fast$0(OCoLC)fst00810501
650 7 $aAntineoplastic agents$xSide effects.$2fast$0(OCoLC)fst00810605
650 7 $aCancer$xChemotherapy$xComplications$xTreatment.$2fast$0(OCoLC)fst00845329
650 7 $aSerotonin$xAntagonists.$2fast$0(OCoLC)fst01113326
650 7 $aSerotonin uptake inhibitors.$2fast$0(OCoLC)fst01113335
650 7 $aErbrechen$2gnd
650 7 $aSerotoninantagonist$2gnd
650 7 $aPharmakotherapie$2gnd
650 7 $aKongress$2gnd
650 7 $aU belkeit$2gnd
650 7 $aSerotoninstoffwechsel$2gnd
650 12 $aSerotonin Antagonists$xtherapeutic use.
650 22 $aAntiemetics.
650 22 $aAntineoplastic Agents$xadverse effects.
650 22 $aNausea$xdrug therapy.
653 0 $aHumans$aCancer$aDrug therapy
653 1 $aHumans$aCancer$aDrug therapy
655 4 $aConference proceedings.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 2 $aCongress.
700 1 $aReynolds, D. J. M.
700 1 $aAndrews, P. L. R.$q(Paul L. R.)
700 1 $aDavis, C. J.$q(Christopher John),$d1950-
710 2 $aOxford Clinical Communications.
938 $aBaker and Taylor$bBTCP$n97140252
029 1 $aAU@$b000012299907
029 1 $aGEBAY$b2785855
029 1 $aNLM$b9711596
029 1 $aUKMGB$b006338387
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 26 OTHER HOLDINGS